(Q49076107)

18 February 2018

title

Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison (English)

1 reference

18 February 2018

adaptive radiation therapy

main subject

0 references

1 reference

De Meerleer GO

1

1 reference

18 February 2018

Vakaet LA

2

1 reference

18 February 2018

De Gersem WR

3

1 reference

18 February 2018

De Wagter C

4

1 reference

18 February 2018

De Naeyer B

5

1 reference

18 February 2018

De Neve W

6

1 reference

18 February 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

18 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

18 February 2018

volume

47

1 reference

18 February 2018

issue

3

1 reference

18 February 2018

page(s)

639-648

1 reference

18 February 2018

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Results of 3D conformal radiotherapy in the treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Indications for excluding the seminal vesicles when treating clinically localized prostatic adenocarcinoma with radiotherapy alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

A feasibility study of automated inverse treatment planning for cancer of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

A comparison of conventional 'forward planning' with inverse planning for 3D conformal radiotherapy of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Enhancement of prostate tumor volume definition with intravesical contrast: a three-dimensional dosimetric evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

A critical evaluation of the planning target volume for 3-D conformal radiotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Conformal radiotherapy of Stage III non-small cell lung cancer: a class solution involving non-coplanar intensity-modulated beams

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Complication probability as assessed from dose-volume histograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Potential clinical efficacy of intensity-modulated conformal therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Fitting of normal tissue tolerance data to an analytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Multiple two-dimensional versus three-dimensional PTV definition in treatment planning for conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

Optimization of intensity-modulated 3D conformal treatment plans based on biological indices

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900419-3

7 January 2021

10.1016/S0360-3016(00)00419-3

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018